Upfront surgery is considered the best therapeutic approach for mature teratoma-type mediastinal germ cell tumors, without very high-risk features, including elevated tumor markers.

Surgery for residual disease after chemotherapy is considered the standard of care and is timed based on the normalization of tumor markers and in those patients where the disease is limited to one site.